Assessment of adverse effects of neurotropic drugs in monkeys with the “Drug Effects on the Nervous System” (DENS) scale
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 215 (1) , 97-102
Abstract
No abstract availableKeywords
Funding Information
- NIH (NS045962, NS073994)
- ORIP/OD (P51OD011132)
- Pfizer, Inc
This publication has 22 references indexed in Scilit:
- Revolution StalledScience Translational Medicine, 2012
- Antagonism of serotonergic 5‐HT2A/2Creceptors: mutual improvement of sleep, cognition and mood?European Journal of Neuroscience, 2009
- Computing inter‐rater reliability and its variance in the presence of high agreementBritish Journal of Mathematical and Statistical Psychology, 2008
- Central Nervous System Pharmacokinetics of the Mdr1 P-Glycoprotein Substrate CP-615,003: Intersite Differences and Implications for Human Receptor Occupancy Projections from Cerebrospinal Fluid ExposuresDrug Metabolism and Disposition, 2007
- Prolongation of levodopa responses by glycineB antagonists in parkinsonian primatesAnnals of Neurology, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Evaluation of Dopamine D-2 Receptor Occupancy by Clozapine, Risperidone, and Haloperidol In Vivo in the Rodent and Nonhuman Primate Brain Using 18F-FallyprideNeuropsychopharmacology, 2001
- A Self-Rating Scale for Measuring Neuroleptic Side-EffectsThe British Journal of Psychiatry, 1995
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- “Mini-mental state”Journal of Psychiatric Research, 1975